Slow continuous ultrafiltration using central vs peripheral line: feasibility of implementation, safety and efficacy in acute heart failure syndromes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
33
Ultrafiltration therapy though peripheral line, two peripheral venous catheter will be placed in the arms.
Ultrafiltration therapy through central line, a central venous catheter will be placed in internal jugular or femoral vein.
Cardiology Service, Hospital del Mar. Passeig Maritim 25-29,
Barcelona, Barcelona, Spain
Efficacy
Compare patient global improvement 48 hours after initiation of scuf therapy in a group of patients with the same features treated by peripheral access against a group of patients with the same features treated by central access. This outcome will be measured by patient global assessment
Time frame: 48 hours after initiation of scuf therapy
Security
Compare complications in acute heart failure patients treated with scuf, in a group treated by peripheral line vs central line. This outcome will be assessed by a safety score at the AE at the 5th day of the study. ( 0 : no AE and 79 understood as the worse punctuation for the AE). Every AE has a punctuation related to the seriousness.
Time frame: 5th day of the study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.